We are live on ! Find out more
PHAS

PhaseBio Pharmaceuticals, Inc. Common Stock

Delisted

PHAS was delisted on the 2nd of November, 2022.

Name Holding Trade Value Shares
Change
Change in
Stake
NMC
1
NEA Management Company
Maryland
$20.7M
APM
2
Avidity Partners Management
Texas
$13.7M +$300K +90,000 +2%
Wellington Management Group
3
Wellington Management Group
Massachusetts
$12.5M -$1.72M -515,239 -11%
RCM
4
RA Capital Management
Massachusetts
$8.86M
Vanguard Group
5
Vanguard Group
Pennsylvania
$5.83M +$19.7K +5,909 +0.3%
RSCM
6
Rock Springs Capital Management
Maryland
$5.73M
JJ
7
Johnson & Johnson
New Jersey
$5M +$5.36M +1,607,044 New
ECM
8
Endurant Capital Management
California
$3.52M -$3.33M -997,186 -47%
CS
9
Candriam SCA
Luxembourg
$3.36M +$1.54M +461,824 +75%
ACM
10
Altium Capital Management
New York
$2.41M
DCM
11
DAFNA Capital Management
California
$1.88M
BlackRock
12
BlackRock
New York
$1.61M +$108K +32,335 +7%
EP
13
Eversept Partners
New York
$933K +$1M +300,000 New
Millennium Management
14
Millennium Management
New York
$932K +$308K +92,273 +44%
Stifel Financial
15
Stifel Financial
Missouri
$911K +$101K +30,147 +11%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$872K +$283K +84,729 +43%
CCM
17
CAAS Capital Management
New York
$818K +$878K +263,172 New
PTP
18
Platform Technology Partners
New York
$713K -$501 -150 -0.1%
Marshall Wace
19
Marshall Wace
United Kingdom
$681K +$730K +218,877 New
BCM
20
Bridgeway Capital Management
Texas
$639K +$390K +117,000 +132%
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
$561K +$411K +123,075 +215%
O
22
OrbiMed
New York
$551K +$591K +177,113 New
Morgan Stanley
23
Morgan Stanley
New York
$464K +$67K +20,081 +16%
Renaissance Technologies
24
Renaissance Technologies
New York
$313K +$336K +100,566 New
OIA
25
OneDigital Investment Advisors
Kansas
$274K +$119K +35,700 +68%